JP2024547218A5 - - Google Patents
Info
- Publication number
- JP2024547218A5 JP2024547218A5 JP2024556825A JP2024556825A JP2024547218A5 JP 2024547218 A5 JP2024547218 A5 JP 2024547218A5 JP 2024556825 A JP2024556825 A JP 2024556825A JP 2024556825 A JP2024556825 A JP 2024556825A JP 2024547218 A5 JP2024547218 A5 JP 2024547218A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- seq
- domain
- polypeptide
- acetylcholine receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288782P | 2021-12-13 | 2021-12-13 | |
| US63/288,782 | 2021-12-13 | ||
| PCT/IL2022/051321 WO2023112028A1 (en) | 2021-12-13 | 2022-12-13 | Ig-like fusion proteins and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024547218A JP2024547218A (ja) | 2024-12-26 |
| JP2024547218A5 true JP2024547218A5 (enExample) | 2025-12-23 |
Family
ID=86774007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556825A Pending JP2024547218A (ja) | 2021-12-13 | 2022-12-13 | Ｉｇ様融合タンパク質およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250059255A1 (enExample) |
| EP (1) | EP4447993A4 (enExample) |
| JP (1) | JP2024547218A (enExample) |
| CN (1) | CN118678964A (enExample) |
| CA (1) | CA3240617A1 (enExample) |
| WO (1) | WO2023112028A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025541324A (ja) * | 2022-12-13 | 2025-12-18 | キャノピー イムノ‐セラピューティクス リミテッド | 重症筋無力症を治療するためのｉｇ様融合タンパク質 |
| AU2024315618A1 (en) * | 2023-08-01 | 2026-01-22 | Merida Biosciences, Inc. | Molecules for controlling autoimmune response |
| CN121941504A (zh) * | 2023-08-01 | 2026-04-28 | 梅里达生物科学公司 | 用于控制自身免疫反应的分子 |
| WO2025126210A1 (en) * | 2023-12-13 | 2025-06-19 | Canopy Immuno-Therapeutics Ltd. | Ig-like fusion proteins for treating musk myasthenia gravis |
| WO2025126216A1 (en) * | 2023-12-13 | 2025-06-19 | Canopy Immuno-Therapeutics Ltd. | Improved acetylcholine receptor molecules and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100719020B1 (ko) * | 2005-09-28 | 2007-05-17 | 광주과학기술원 | 재조합 아세틸콜린 수용체 폴리펩티드, 폴리펩티드 유도체및 이를 유효성분으로 포함하는 중증근무력증 치료제 |
| JP4857396B1 (ja) * | 2011-04-13 | 2012-01-18 | 日本製薬株式会社 | 融合蛋白質 |
| WO2016044137A2 (en) * | 2014-09-15 | 2016-03-24 | The Trustees Of The University Of Pennsylvania | Acetylcholine receptor-specific immunosuppressive compositions and methods of treatment of myasthenia gravis |
-
2022
- 2022-12-13 CN CN202280091480.XA patent/CN118678964A/zh active Pending
- 2022-12-13 WO PCT/IL2022/051321 patent/WO2023112028A1/en not_active Ceased
- 2022-12-13 CA CA3240617A patent/CA3240617A1/en active Pending
- 2022-12-13 EP EP22906854.9A patent/EP4447993A4/en active Pending
- 2022-12-13 US US18/719,727 patent/US20250059255A1/en active Pending
- 2022-12-13 JP JP2024556825A patent/JP2024547218A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024547218A5 (enExample) | ||
| JP6783797B2 (ja) | 抗がん融合ポリペプチド | |
| JP7682927B2 (ja) | 特異的結合性分子 | |
| KR20180090374A (ko) | Ny-eso-1 종양 항원-hla-a*02 복합체에 특이적인 t 세포 수용체 | |
| CN112110995A (zh) | 肿瘤新抗原多肽及其用途 | |
| WO2020186974A1 (zh) | 一种双特异性抗体及其制备方法与应用 | |
| JP2022522404A (ja) | Ｔ細胞調節抗原提示ポリペプチド及びその使用方法 | |
| EA012507B1 (ru) | Высокоаффинные мелан-а т-клеточные рецепторы | |
| WO2022166728A1 (zh) | 双特异性抗体 | |
| CN112533629A (zh) | 结合使用il-10药剂与嵌合抗原受体细胞疗法的组合物和方法 | |
| CN107223133B (zh) | 一种可溶的异质二聚t细胞受体及其制法和应用 | |
| CN111138521B (zh) | 源自于afp抗原的短肽 | |
| CN112262213A (zh) | 新型抗pad2抗体 | |
| CA3218571A1 (en) | Methods of screening and expression of disulfide-bonded binding polypeptides | |
| CN106478797B (zh) | 源自于sage1的肿瘤抗原短肽 | |
| AU2021386892A9 (en) | Polypeptides targeting dr4 and/or dr5 and related compositions and methods | |
| CN107936109A (zh) | 衍生自sage1的肿瘤抗原短肽 | |
| JP2024546875A5 (enExample) | ||
| JP2024546916A5 (enExample) | ||
| WO2022105922A1 (zh) | 源自于ssx2抗原的短肽 | |
| CN116836260A (zh) | 一种识别mage-a4的t细胞受体及其编码序列和应用 | |
| CN107266552A (zh) | 源自于prame的肿瘤抗原短肽 | |
| CN116348481A (zh) | 使用工程化配体的材料和方法 | |
| CN108218977A (zh) | 源自于肿瘤抗原sage1的短肽 | |
| CN110862449B (zh) | 衍生自ssx的肿瘤抗原短肽 |